(VIANEWS) – OKEANIS ECO TANKER (OET.OL), ODFJELL DRILLING (ODL.OL), SONAE (SON.LS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. OKEANIS ECO TANKER (OET.OL)
1384.1% sales growth and 28.08% return on equity
Okeanis Eco Tankers Corp., a shipping company, owns and operates tanker vessels worldwide. It operates a fleet of 14 tanker vessels comprising six modern Suezmax tankers and eight modern VLCC tankers focusing on the transportation of crude oil. The company was incorporated in 2018 and is based in Neo Faliro, Greece.
Earnings Per Share
As for profitability, OKEANIS ECO TANKER has a trailing twelve months EPS of kr40.3.
PE Ratio
OKEANIS ECO TANKER has a trailing twelve months price to earnings ratio of 9.19. Meaning, the purchaser of the share is investing kr9.19 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.08%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.5%, now sitting on 403.85M for the twelve trailing months.
Volume
Today’s last reported volume for OKEANIS ECO TANKER is 14179 which is 69.48% below its average volume of 46467.
Moving Average
OKEANIS ECO TANKER’s worth is way above its 50-day moving average of kr333.40 and way above its 200-day moving average of kr326.30.
Yearly Top and Bottom Value
OKEANIS ECO TANKER’s stock is valued at kr370.50 at 07:20 EST, below its 52-week high of kr387.00 and way above its 52-week low of kr250.00.
More news about OKEANIS ECO TANKER.
2. ODFJELL DRILLING (ODL.OL)
997.7% sales growth and 18.26% return on equity
Odfjell Drilling Ltd. owns and operates mobile offshore drilling units primarily in Norway and Namibia. The company operates through Own Fleet and External Fleet segments. It also offers management services to other owners of drilling units, such as operational management, regulatory requirements management, marketing, contract negotiations and client relations, and operation and mobilization preparation services. The company was founded in 1914 and is headquartered in Aberdeen, the United Kingdom. Odfjell Drilling Ltd. is a subsidiary of Odfjell Partners Holding Ltd.
Earnings Per Share
As for profitability, ODFJELL DRILLING has a trailing twelve months EPS of kr10.75.
PE Ratio
ODFJELL DRILLING has a trailing twelve months price to earnings ratio of 4.94. Meaning, the purchaser of the share is investing kr4.94 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.26%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 32.7% and a drop 9.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 763.5M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 30, 2024, the estimated forward annual dividend rate is 2.54 and the estimated forward annual dividend yield is 4.71%.
Moving Average
ODFJELL DRILLING’s value is under its 50-day moving average of kr53.32 and higher than its 200-day moving average of kr50.04.
More news about ODFJELL DRILLING.
3. SONAE (SON.LS)
10.5% sales growth and 9.35% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. operates as a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.19.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 4.99. Meaning, the purchaser of the share is investing €4.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.35%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 8.34B for the twelve trailing months.
More news about SONAE.
4. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. The company was incorporated in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.48.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 19.14. Meaning, the purchaser of the share is investing kr19.14 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 3.22B for the twelve trailing months.
More news about BOUVET.
5. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Volume
Today’s last reported volume for SANOFI is 1839940 which is 37.38% above its average volume of 1339290.
More news about SANOFI.
